ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2025

Autonomic Nervous System Dysfunction Common Among Patients with Long COVID:Diagnosis and Treatment Implications

Norman Gaylis1, Odence DeLaRosa2, Joanne Sagliani1 and Andrew Holman3, 1Arthritis & Rheumatic Disease Specialties, Aventura, FL, 2Arthritis & Rheumatic Disease Specialties., Aventura, FL, 3Inmedix, Inc, Seattle, WA

Meeting: ACR Convergence 2024

Keywords: Autoinflammatory diseases, COVID-19

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Miscellaneous Rheumatic & Inflammatory Diseases Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Up to 70% of the 236 million people who have been diagnosed with COVID-19 develop some post-COVID symptoms, i.e. post-acute sequalae of SARS-CoV-2 (PASC) or Long COVID.(1) Long-COVID causes significant physical and mental limitations,(2) including multiple symptoms and organ involvement, even two years after infection.(3)  We and others have reported autonomic nervous system (ANS) dysfunction as a contributor to these complaints.(3,4,5) This abstract follows up our ACR2022 report (4) on the importance of medical grade heart rate variability (HRV) as a valuable diagnostic tool in confirming ANS dysfunction in Long- COVID patients. The primary objective of this study was to report an ongoing evaluation of patients with Long-COVID, with symptoms of multiple diversity, and to confirm the value of measuring medical grade HRV, and consider attribution of symptoms to dysautonomia.

Methods: Patients with Long-COVID (definitive diagnostic evidence and symptoms for post COVID for at least 3 months) were evaluated in a single COVID clinic in Florida.  These patients displayed multiple symptoms (Table 1). ANS function in all patients was measured by 5-min, supine HRV (Inmedix, Normandy Park, WA, USA ). Standard 1996 time-and frequency-domain and 2002 Bayevsky (6) HRV indices were assessed (Omegawave Oy, Espoo, Finland). 

Results: A majority (62.7%) of 102 patients with Long COVID tested (mean age:43 yrs; mean duration:15 mo.) showed findings of dysautonomia by abnormal resting HRV.  (Table 2)   Of the 62.7% patients with clinical findings of ANS dysfunction, 90.6% had low parasympathetic activity, 73% had increased sympathetic activity and 98.4% had increased levels of tension. Significant symptoms of dysautonomia were fatigue (83.3%), dyscognition (55.8%), neurological (45%), gastrointestinal (31.3%), cardiac (24.5%) and depression or anxiety (29.4%).  (Table 2)

Conclusion: Long COVID or post-acute sequalae of SARS-CoV-2 (PASC) patients, are often evaluated by rheumatologists. We have confirmed that ANS dysregulation documented by medical grade HRV was prominent among this patient population. Others have reported the interplay between the ANS and inflammation across systemic autoimmune disorders (7,8,9). Utilizing the abnormal HRV findings – whether increased sympathetic findings, decreased parasympathetic findings or both – may reveal an opportunity to address ANS imbalance and subsequently ameliorate this morbidity.

Further exploration of ANS abnormalities and application of medical-grade HRV in Long COVID is warranted.

     REFERENCES

1. Lancet Respir Med. 20219(11):1275-1287.

2. Center for Disease Control (CDC) 2023;72(32);866-870.

3. Fernandez-de-las-Penas et al. J Infect. 2024;88(2);77-88.

4. Gaylis, et al. Arthritis Rheumatol. 2022; 74 (suppl 9).

5. Dani, M et al. ClinMed 2020-0896.

6.  Bayevsky RM, , et al. HRV Analysis under the usage of different electrocardiography systems prepared according to the order of the Committee of Clinic Diagnostic Apparatus and the Committee of New Medical Techniques of Ministry of Health of Russia (protocol №4 from the 11APR2002).

7.  Sharma, C. Nature Reviews Rheumatology 2023;19, 399-404.

Supporting image 1

Table 1

Supporting image 2


Disclosures: N. Gaylis: None; O. DeLaRosa: None; J. Sagliani: None; A. Holman: None.

To cite this abstract in AMA style:

Gaylis N, DeLaRosa O, Sagliani J, Holman A. Autonomic Nervous System Dysfunction Common Among Patients with Long COVID:Diagnosis and Treatment Implications [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/autonomic-nervous-system-dysfunction-common-among-patients-with-long-coviddiagnosis-and-treatment-implications/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/autonomic-nervous-system-dysfunction-common-among-patients-with-long-coviddiagnosis-and-treatment-implications/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology